 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Streptomyces plicatus beta-n-acetylhexosaminidase in complex 3r,4s,5r)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperid chloride (ifg)
|
|
Structure:
|
 |
Beta-n-acetylhexosaminidase. Chain: a. Engineered: yes
|
|
Source:
|
 |
Streptomyces plicatus. Organism_taxid: 1922. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
1.75Å
|
R-factor:
|
0.176
|
R-free:
|
0.192
|
|
|
Authors:
|
 |
B.L.Mark,D.J.Vocadlo,D.Zhao,S.Knapp,S.G.Withers,M.N.James
|
Key ref:
|
 |
B.L.Mark
et al.
(2001).
Biochemical and structural assessment of the 1-N-azasugar GalNAc-isofagomine as a potent family 20 beta-N-acetylhexosaminidase inhibitor.
J Biol Chem,
276,
42131-42137.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
30-May-01
|
Release date:
|
21-Nov-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O85361
(O85361_STRPL) -
B-N-acetylhexosaminidase
|
|
|
|
Seq: Struc:
|
 |
 |
 |
506 a.a.
499 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
carbohydrate metabolic process
|
1 term
|
 |
|
Biochemical function
|
catalytic activity
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
276:42131-42137
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Biochemical and structural assessment of the 1-N-azasugar GalNAc-isofagomine as a potent family 20 beta-N-acetylhexosaminidase inhibitor.
|
|
B.L.Mark,
D.J.Vocadlo,
D.Zhao,
S.Knapp,
S.G.Withers,
M.N.James.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Azasugar inhibitors of the isofagomine class are potent competitive inhibitors
of configuration-retaining beta-glycosidases. This potency results from the
formation of a strong electrostatic interaction between a protonated endocyclic
nitrogen at the "anomeric" center of the inhibitor and the catalytic
nucleophile of the enzyme. Although the majority of retaining beta-glycosidases
use a mechanism involving a carboxylate residue as a nucleophile, Streptomyces
plicatus beta-N-acetylhexos-aminidase (SpHEX) and related family 20 glycosidases
lack such a catalytic residue and use instead the carbonyl oxygen of the
2-acetamido group of the substrate as a nucleophile to "attack" the
anomeric center. Thus, a strong electrostatic interaction between the inhibitor
and enzyme is not expected to occur; nonetheless, the 1-N-azasugar
(2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidinium
hydrochloride (GalNAc-isofagomine.HCl), which was synthesized and assayed for
its ability to inhibit SpHEX, was found to be a potent competitive inhibitor of
the enzyme (K(i) = 2.7 microm). A crystallographic complex of GalNAc-isofagomine
bound to SpHEX was solved and refined to 1.75 A and revealed that the lack of a
strong electrostatic interaction between the "anomeric" center of
GalNAc-isofagomine and SpHEX is compensated for by a novel 2.8-A hydrogen bond
formed between the equatorial proton of the endocyclic nitrogen of the azasugar
ring and the carboxylate of the general acid-base residue Glu-314 of SpHEX. This
interaction appears to contribute to the unexpected potency of
GalNAc-isofagomine toward SpHEX.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Inhibition of SpHEX-catalyzed hydrolysis of
pNPGlcNAc by GalNAc-isofagomine (3, Fig. 2). The concentrations
of GalNAc-isofagomine were 0.62 ( circle ),
1.23 ( ), 3.08
( ), 6.15
( ), 9.23 (
), and 18.5
( ) µM.
|
 |
Figure 5.
Fig. 5. Schematic of the hydrogen-bonding interactions
occurring between SpHEX and GalNAc-isofagomine (3, Fig. 2).
Hydrogen bonds are shown as dashed lines, and their respective
distances are indicated in Ångstroms. GalNAc-isofagomine
is shown in blue, and the SpHEX residue side chains are shown in
black and numbered. No attempt has been made to locate the true
positions of the amino acid side chains.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2001,
276,
42131-42137)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Usuki,
Y.Yamamoto,
Y.Kumagai,
T.Nitoda,
H.Kanzaki,
and
T.Hatanaka
(2011).
MS/MS fragmentation-guided search of TMG-chitooligomycins and their structure-activity relationship in specific β-N-acetylglucosaminidase inhibition.
|
| |
Org Biomol Chem, 9,
2943-2951.
|
 |
|
|
|
|
 |
A.Lammerts van Bueren,
S.D.Popat,
C.H.Lin,
and
G.J.Davies
(2010).
Structural and thermodynamic analyses of α-L-fucosidase inhibitors.
|
| |
Chembiochem, 11,
1971-1974.
|
 |
|
|
|
|
 |
H.C.Dorfmueller,
V.S.Borodkin,
M.Schimpl,
and
D.M.van Aalten
(2009).
GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation.
|
| |
Biochem J, 420,
221-227.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.D.Hill,
and
P.J.Reilly
(2008).
A Gibbs free energy correlation for automated docking of carbohydrates.
|
| |
J Comput Chem, 29,
1131-1141.
|
 |
|
|
|
|
 |
R.Hurtado-Guerrero,
H.C.Dorfmueller,
and
D.M.van Aalten
(2008).
Molecular mechanisms of O-GlcNAcylation.
|
| |
Curr Opin Struct Biol, 18,
551-557.
|
 |
|
|
|
|
 |
R.Ettrich,
V.Kopecký,
K.Hofbauerová,
V.Baumruk,
P.Novák,
P.Pompach,
P.Man,
O.Plíhal,
M.Kutý,
N.Kulik,
J.Sklenár,
H.Ryslavá,
V.Kren,
and
K.Bezouska
(2007).
Structure of the dimeric N-glycosylated form of fungal beta-N-acetylhexosaminidase revealed by computer modeling, vibrational spectroscopy, and biochemical studies.
|
| |
BMC Struct Biol, 7,
32.
|
 |
|
|
|
|
 |
C.Mayer,
D.J.Vocadlo,
M.Mah,
K.Rupitz,
D.Stoll,
R.A.Warren,
and
S.G.Withers
(2006).
Characterization of a beta-N-acetylhexosaminidase and a beta-N-acetylglucosaminidase/beta-glucosidase from Cellulomonas fimi.
|
| |
FEBS J, 273,
2929-2941.
|
 |
|
|
|
|
 |
F.V.Rao,
H.C.Dorfmueller,
F.Villa,
M.Allwood,
I.M.Eggleston,
and
D.M.van Aalten
(2006).
Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
|
| |
EMBO J, 25,
1569-1578.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.L.Mark,
D.J.Mahuran,
M.M.Cherney,
D.Zhao,
S.Knapp,
and
M.N.James
(2003).
Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
|
| |
J Mol Biol, 327,
1093-1109.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Vasella,
G.J.Davies,
and
M.Böhm
(2002).
Glycosidase mechanisms.
|
| |
Curr Opin Chem Biol, 6,
619-629.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|